OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Michael Parker

2 Projects | 1 Researchers | $913,407 Invested

2022

St. Vincent's Institute of Medical Research

Michael Parker, DPhil

Development of small molecule inhibitors of a microglia receptor as treatments for Alzheimer’s disease

  • Funding Amount: $567,653
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Active

2017

St. Vincent's Institute of Medical Research

Michael Parker, DPhil

Activation of microglial cells to promote clearance of amyloid-beta

  • Funding Amount: $345,754
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed